3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.

By C. Roux, A. Astrup, K. Fujioka, F. Greenway, D. Lau, L. Gaal, R. Ortíz, John P H Wilding, T. V. Skjøth, L. S. Manning and 186 more. The Lancet, 2017

646 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Molecular Biology, Physiology

View Paper: https://www.semanticscholar.org/paper/17dd8f0f5da3ac8a055d2e03a84520e21a2a8295